Stem Pharm

company

About

Stem Pharm's synthetic biomaterials support the optimization of cell expansion.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$290K
Industries
Biopharma,Biotechnology,Life Science,Pharmaceutical
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Stem Pharm was founded in 2015 with the purpose of being a trusted supplier of synthetic biomaterials that are specifically designed to meet customer's requirements as they develop more advanced cellular models for drug discovery and toxicity screening and cellular therapies for regenerative medicine applications. Stem Pharm is located in the Fitchburg Technology Campus, near the University of Wisconsin campus. It Leverages its expertise in biomaterials and cellular interactions to develop high-value applications of organoids (3-D in vitro models) for drug discovery and cell-friendly coatings for the manufacture of-cell based therapies.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$290K
Stem Pharm has raised a total of $290K in funding over 2 rounds. Their latest funding was raised on Jan 20, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 20, 2017 Grant $290K 1 National Institutes of Health Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Stem Pharm is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant